Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
Clinical trial NCT03521063 · UNKNOWN
Trial details
- NCT number
- NCT03521063
- Sponsor
- Hospital Central "Dr. Ignacio Morones Prieto"
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2019-10-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.